An additional eight abstracts presented during EADV
reported on efficacy, safety and patient-reported outcome data from the TREMFYA Phase 3 moderate to severe plaque psoriasis clinical development program.
With our new data at EADV
2014 and the record-breaking enrolment timeline of the CLEAR study, we are excited to continue generating important clinical evidence of the impact of secukinumab and Xolair on patients.
Congress is being held from 27-30 September 2012 in Prague, Czech Republic, added the company.
BY BRUCE JANCIN EXPERT ANALYSIS FROM THE EADV
In addition to the successful phase II study of OPA-15406 he presented, a highlight of the EADV
congress was the strongly positive pivotal phase III data presented for crisaborole, another nonsteroidal topical PDE-4 inhibitor, albeit with a different mechanism of action.
Based on our technology's robust scientific foundation, we expect considerable interest in SmoothShapes from dermatologists attending the EADV
Congress," said Nancy M.
EXPERT ANALYSIS FROM THE ANNUAL CONGRESS OF THE EADV
Erwin Tschachler, EADV
secretary general--elect, singled out Dr.
Four posters will be presented at The 17th Congress of the European Academy of Dermatology, EADV
Conference being held at the Palais Des Congres 2 in Paris, France, September 17-21, 2008.
As a leading forum for dermatologists from around the world, we are pleased to share a variety of data from across our immunology portfolio at EADV
," said Dr.
Svenungsson said in her keynote lecture at the meeting of the European Society of Cutaneous Lupus Erythematosus, which was held in conjunction with the EADV
00 AM on the EADV
app, with a corresponding abstract number and an e-poster number, or presentation number.